Archive - August 2019
Turalio becomes first FDA-approved treatment for tenosynovial giant cell tumour
AZ’ Forxiga label updated in EU for type II diabetes
Sosei Heptares, Takeda embark on strategic R&D partnership
New PM pledges £1.8bn to NHS
Positive first-line phase 3 results for Tecentriq
Boris pledges a £1.8bn cash injection for the NHS
Transgene slumps as viral cancer therapy fails phase 3 trial
A broad range of companies have committed to the 2019 Communications Team of the Year competition
